Neuroendocrine Tumors — Trials, FDA Actions & Pivotal Research

20 active Neuroendocrine Tumors trials currently recruiting in the US, sourced from ClinicalTrials.gov.

Synced daily from openFDA and ClinicalTrials.gov. Last sync: July 13, 2026.

Recruiting trials by city

Cities where Neuroendocrine Tumors trials in our archive had recruiting sites. Each link lists every currently recruiting paid clinical trial at that location.

Ann Arbor, MI Detroit, MI Los Angeles, CA San Francisco, CA Birmingham, AL Boston, MA Cleveland, OH Columbus, OH Duarte, CA Gainesville, FL Jacksonville, FL La Jolla, CA

Active Neuroendocrine Tumors trials

Currently recruiting US trials matching Neuroendocrine Tumors, sourced live from ClinicalTrials.gov. We’ll add per-event articles here as those trials post results or hit primary completion.

Study of CTX-471 in Patients With Neural Cell Adhesion Molecule (NCAM) Positive Neuroendocrine Neoplasms

for Neuroendocrine Neoplasm

Sponsor: Compass Therapeutics

Sex: All·Age: 18+

Code: NCT07684170·Phase 2·Not Yet Recruiting·Listed Jul 6, 2026

Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation for the Treatment of Pancreatic Neoplasms

for Pancreatic Neoplasm

1 location in Columbus

Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All·Age: 18+

Code: NCT07619417·Not Yet Recruiting·Listed Jun 2, 2026

211At-MABG in Adults With Advanced Neuroendocrine Cancers

for Pheochromocytoma

1 location in Philadelphia

Sponsor: University of Pennsylvania

Sex: All·Age: 18+

Code: NCT07661420·Phase 1·Not Yet Recruiting·Listed Jun 22, 2026

A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine Carcinoma

for Neuroendocrine Carcinoma

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Sex: All·Age: 18 - 75

Code: NCT07595913·Phase 3·Not Yet Recruiting·Listed May 19, 2026

A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate

for Neuroendocrine Tumor of the Lung

7 locations incl. Basking Ridge

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT06941480·Phase 1·Not Yet Recruiting

A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

for Gastroenteropancreatic Neuroendocrine Tumor

1 location in East Hanover

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 110

Code: NCT07635316·Recruiting·Listed Jun 9, 2026

Apply to this trial

CardioNETPOL National Registry of Carcinoid Heart Disease

for Carcinoid Heart Disease

Sponsor: National Institute of Cardiology, Warsaw, Poland

Sex: All·Age: 18+

Code: NCT07450287·Not Yet Recruiting

A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC

for SCLC

Sponsor: Shanghai Henlius Biotech

Sex: All·Age: 18 - 75

Code: NCT07416695·Phase 1·Recruiting

Apply to this trial

Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors

for Neuroendocrine Neoplasms (Tumours)

Sponsor: Tata Memorial Hospital

Sex: All·Age: 18 - 70

Code: NCT07404176·Phase 2·Recruiting

Apply to this trial

AI-Powered Precision Decision-Making for Pancreatic Diseases

for Pancreatic Cancer

Sponsor: Changhai Hospital

Sex: All·Age: 18 - 80

Code: NCT07439757·Recruiting

Apply to this trial

Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients

for SCLC, Extensive Stage

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Sex: All·Age: 18 - 75

Code: NCT07366658·Phase 1·Recruiting

Apply to this trial

Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs)

for Neuroendocrine Carcinoma

Sponsor: Intergroupe Francophone de Cancerologie Thoracique

Sex: All·Age: 18+

Code: NCT06937905·Phase 3·Recruiting

Apply to this trial

Sensing Oxygen Saturations Using Abdominal NIRS With an Investigational Realtime Device (Songbird)

for NEC

Sponsor: Carag AG

Sex: All·Age: 1 Day - 7 Days

Code: NCT05278247·Not Yet Recruiting

Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy

for Pancreatic Ductal Adenocarcinoma

Sponsor: Minia University

Sex: All·Age: 18 - 75

Code: NCT07328607·Recruiting

Apply to this trial

Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not

for Pancreatic Neuroendocrine Tumor

Sponsor: Uppsala University

Sex: All·Age: 18+

Code: NCT07273409·Recruiting

Apply to this trial

18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms

for Neuroendocrine Tumors

Sponsor: First Affiliated Hospital of Zhejiang University

Sex: All·Age: 20 - 80

Code: NCT07102056·Not Yet Recruiting

Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment

for Neuroendocrine Tumors

Sponsor: Ipsen

Sex: All·Age: 18+

Code: NCT07314164·Recruiting

Apply to this trial

Sapu003 in Advanced mTOR-sensitive Solid Tumors

for Breast Cancer Metastatic

Sponsor: SAPU NANO (US) LLC

Sex: All·Age: 18+

Code: NCT07369505·Phase 1·Recruiting

Apply to this trial

DCEUS to Assess Treatment Response to PRRT in GEP-NET

for NET

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Sex: All·Age: 18+

Code: NCT07319416·Recruiting

Apply to this trial

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

for GEP-NET

7 locations incl. Iowa City

Sponsor: RayzeBio, Inc.

Sex: All·Age: 18+

Code: NCT07165132·Phase 1·Recruiting

Apply to this trial